Molecule intelOpportunity: ModerateEssential

Furosemide

51 brands · 28 companies · product forms

ATC: C03CA01

Opportunity snapshot

Launch attractiveness
40
Market saturation
75
Price room
100
Regulatory risk
0
51
brands
28
companies
Rs 254.9
median price
54
price points
26.16x
price spread
100
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 8%

Price room

Across observed sources and strengths
CheapestRs 60.57
MedianRs 254.9
Most expensiveRs 1,584.75
Spread26.16×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 26.16x across 54 trusted points (Rs 60.57-1584.75). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 12 live products for Furosemide — each links to its own medicine page.

Why this score

Launch attractiveness

40% supply-gap(25) + 25% price-variation(100) + 20% low-competition(25) + 15% supply-disruption(0), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

28 canonical companies and 51 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 26.16x across 54 trusted points (Rs 60.57-1584.75). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Full coverage.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.